211 related articles for article (PubMed ID: 36105397)
1. Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials.
Auttara-Atthakorn A; Sungmala J; Anothaisintawee T; Reutrakul S; Sriphrapradang C
Front Endocrinol (Lausanne); 2022; 13():960265. PubMed ID: 36105397
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
Riley P; Glenny AM; Hua F; Worthington HV
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012744. PubMed ID: 28759701
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
4. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.
Ma C; Xie J; Chen Q; Wang G; Zuo S
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD007956. PubMed ID: 19821441
[TBL] [Abstract][Full Text] [Related]
5. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
[TBL] [Abstract][Full Text] [Related]
6. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid cancer and selenium supplements for protection of salivary glands from
Mazokopakis E
Hell J Nucl Med; 2018; 21(1):83-84. PubMed ID: 29550852
[TBL] [Abstract][Full Text] [Related]
8. The effect of selenium supplementation on sonographic findings of salivary glands in papillary thyroid cancer (PTC) patients treated with radioactive iodine: study protocol for a double-blind, randomized, placebo-controlled clinical trial.
Amini S; Golshani M; Moslehi M; Hajiahmadi S; Askari G; Iraj B; Bagherniya M
Trials; 2023 Aug; 24(1):501. PubMed ID: 37550760
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
10. Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?
Adramerinas M; Andreadis D; Vahtsevanos K; Poulopoulos A; Pazaitou-Panayiotou K
Hormones (Athens); 2021 Dec; 20(4):669-678. PubMed ID: 34143403
[TBL] [Abstract][Full Text] [Related]
11. Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment.
Torun N; Muratli A; Serim BD; Ergulen A; Altun GD
Curr Med Imaging Rev; 2019; 15(4):395-404. PubMed ID: 31989909
[TBL] [Abstract][Full Text] [Related]
12. Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.
Ma C; Xie J; Jiang Z; Wang G; Zuo S
Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1778-85. PubMed ID: 20130857
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland function in thyroid cancer patients with radioiodine administration history.
Krcalova E; Horacek J; Gabalec F; Zak P; Dolezal J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):277-283. PubMed ID: 31223135
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.
Bohuslavizki KH; Klutmann S; Jenicke L; Kröger S; Buchert R; Mester J; Clausen M
Cancer Biother Radiopharm; 1999 Oct; 14(5):337-47. PubMed ID: 10850318
[TBL] [Abstract][Full Text] [Related]
15. Insufficient evidence for interventions to prevent dry mouth and salivary gland dysfunction post head and neck radiotherapy.
Ferraiolo DM; Veitz-Keenan A
Evid Based Dent; 2018 Mar; 19(1):30-31. PubMed ID: 29568026
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Bleckmann C; Brenner W; Lassmann S; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Feb; 175(2):57-61. PubMed ID: 10065139
[TBL] [Abstract][Full Text] [Related]
17. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
18. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy.
Bohuslavizki KH; Brenner W; Klutmann S; Hübner RH; Lassmann S; Feyerabend B; Lüttges J; Tinnemeyer S; Clausen M; Henze E
J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
[TBL] [Abstract][Full Text] [Related]
20. Effects of Salivary Secretion Stimulation on the Treatment of Chronic Radioactive Iodine-Induced Sialadenitis.
Choi JS; Hong SB; Hyun IY; Lim JY; Kim YM
Thyroid; 2015 Jul; 25(7):839-45. PubMed ID: 25809840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
